Post Time: 2025-07-18
Error: No content files found.Eli Lilly has launched Mounjaro in India with the approval of the Central Drugs Standard Control Organisation (CDSCO). It is a groundbreaking treatment for obesity and type-2 diabetes. Mounjaro is a one-of-a-kind drug that activates both GIP and GLP-1 hormone slimlife evolution keto gummies receptors, making it highly effective in managing weight and blood sugar levels. As per the press release, in clinical trials patients taking Mounjaro lost an average of 21.8 kg at the highest dose (15 mg) and 15.4 kg at the lowest dose (5 mg) over 72 weeks. bio fuel keto acv gummies The 2.5 mg dose keto gmy gummies is priced at ₹3,500 & the 5 mg dose is priced at ₹4,375. The monthly cost of therapy for the starting dose of 2.5 mg would be approximately ₹14,000. In 2024, Mounjaro generated $11.5 billion in global sales, highlighting its potential in treating diabetes and obesity. #mounjaro #weightlossdrug #elililly #indialaunch #ozempic #type2diabetes #obesity #pharmaceuticalindustry #medicalsupervision #drugpricing #healthcareinnovation #diabetestreatment #weightmanagement #businesstoday ----------------------- Thank You for watching! Do not forget to Like | Comment | Share ----------------------- About the channel Watch us for the best news and views on business, stock markets, crypto currencies, consumer technology, the world of real estate, bullion, automobiles, start-ups and unicorns and personal finance. Business Today TV will also bring you all you need to know about mutual funds, insurance, loans and pension plans among others. Follow us at: Website: WhatsApp: whatsapp.com/channel/0029Va4Hd309hXFCqY62yD2I Facebook: twitter: Instagram: